uric acid has been researched along with 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujikawa, A; Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M; Koizumi, T; Kuwayama, K; Maruyama, H; Ogura, J; Takahashi, N; Takaya, A; Terada, Y; Tsujimoto, T; Yamaguchi, H | 1 |
1 other study(ies) available for uric acid and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester
Article | Year |
---|---|
Intestinal ischemia-reperfusion increases efflux for uric acid via paracellular route in the intestine, but decreases that via transcellular route mediated by BCRP.
Topics: Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Cell Survival; Diketopiperazines; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Mucosa; Intestines; Male; Mitochondria; Neoplasm Proteins; Rats; Rats, Wistar; Reperfusion Injury; Rotenone; Uncoupling Agents; Uric Acid | 2012 |